TA has its place in investing in periods between significant news. The news and approvals etc drive the stock either way and those moves make the chart to which TA is applied. A stick that goes long periods without significant news is ripe for TA. In this CV-19 era and especially for biotechs in the space TA may not be as useful. The pace of announcements just jerks around the stick too much. I use TA to trade stocks that are mostly disconnected from C.V.-19 and it works well. For CYDY I am in and just riding these waves. I have invested what I can afford to lose knowing the the risk/reward setup at 1.17 avg cost basis is worth it.
I’m new to the OTC market and have done lots of research on CyDy and Leronlimab and the science is very compelling that I can understand I read everyone’s post almost everyday and it seems that you and black Ops have two different ways of strategy he draws off of experience from years of being in the field and you use TA to guide a lot of decisions if If my understanding of both strategies are correct I have two questions might there be room for both approaches with with this type of stock as it doesn’t seem to flow in a prescribed manner like a “normal stock” does and with using technicals or they better at predicting short or long term movements with your investments to this point. Thanks for your input
News 
Market Data 
Discover 
